Low-grade oligodendroglioma responds to chemotherapy

Neurology

Volumn 46, Issue 1, 1996, Pages 203-207

  Mason, Warren P ^a,b   Krol, George S ^a   DeAngelis, Lisa M ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PRIORITY JOURNAL;

EID: 0029888804     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.1.203     Document Type: Article

References (22)

1. Russell DS, Rubinstein LJ. Pathology of tumors of the central nervous system. Baltimore: Williams & Wilkins, 1989.
2. Chin HW, Hazel JJ, Kim TH, Webster JH. Oligodendrogliomas. 1. A clinical study of cerebral oligodendrogliomas. Cancer 1980;45:1458-1466.
3. Smith MT, Ludwig CL, Godfrey AD, Armbrustmacher VW. Grading of oligodendrogliomas. Cancer 1983;52:2107-2114.
4. Kros JM, Troost D, Eden CGv, Werf AJMvd, Uylings HBM. Oligodendroglioma: A comparison of two grading systems. Cancer 1987;61:2251-2259.
5. Macdonald DR. Low-grade gliomas, mixed gliomas, and oligodendrogliomas. Semin Oncol 1994;21:236-248.
6. Burger PC, Rawlings CE, Cox EB, et al. Clinicopathologic correlations in the oligodendroglioma. Cancer 1986;59:1345-1352.
7. Shaw EG, Scheithauer BW, O'Fallon JR, Tazelaar HD, Davis DH. Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg 1992;76:428-434.
8. Wallner KE, Gonzales M, Sheline GE. Treatment of oligodendrogliomas with or without postoperative irradiation. J Neurosurg 1988;68:684-688.
9. Walker MD, Alexander E, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 1978;49:333-343.
10. Lindegaard K-F, Mork SJ, Eide GE, et al. Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma. J Neurosurg 1987;67:224-230.
11. Cairncross JG, Macdonald DR. Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 1988;23: 360-364.
12. Cairncross JG, Macdonald DR, Ludwin S, et al. Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 1994;12: 2013-2021.
13. Kyritsis AP, Yung WK, Bruner J, Gleason MJ, Levin VA. The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 1993;32:365-370.
14. Cairncross JG. Aggressive oligodendroglioma: a chemosensitive tumor. Recent Results Cancer Res 1994;135:127-133.
15. Cairncross JG, Macdonald DR, Ramsay DA. Aggressive oligodendroglioma: a chemosensitive tumor. Neurosurgery 1992; 31:78-82.
16. Brown M, Cairncross JG, Vick NA, et al. Differential response of recurrent oligodendrogliomas vs astrocytomas to intravenous (IV) melphalan. Neurology 1990;40(Suppl 1):397-398.
17. Saarinen UM, Pihko H, Makipernaa A. High-dose thiotepa with autologous bone marrow rescue in recurrent malignant oligodendroglioma: a case report. J Neuro-Oncol 1990;9:57-61.
18. Cairncross JG, Laperriere N. Low-grade glioma: to treat or not to treat? Arch Neurol 1989;46:1238-1239.
19. Paleologos NA, Vick NA, Kachoris JP. Chemotherapy for low-grade oligodendrogliomas? Ann Neurol 1994;36:294-295.
20. Glass J, Hochberg FH, Gruber ML, et al. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. J Neurosurg 1992;76:741-745.
21. Macdonald DR, Gaspar LE, Cairncross JG. Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann Neurol 1990;27:573-574.
22. Smith MT, Ludwig CL, Godfrey AD. Grading of oligodendrogliomas. Cancer 1983;62:2107-2114.